61 related articles for article (PubMed ID: 9092696)
1. Combining interferon-alpha2b (IFN) and intravenous immunoglobulins IgG, IgM and IgA (IVIG) in rapid progressive myelofibrosis (MF) with Trisomy 1.
Rewald E; de las Mercedes Francischetti
Am J Hematol; 1997 Apr; 54(4):340. PubMed ID: 9092696
[No Abstract] [Full Text] [Related]
2. Acquired resistance to interferon alpha therapy associated with homozygous MPL-W515L mutation and chromosome 20q deletion in primary myelofibrosis.
Buxhofer-Ausch V; Gisslinger H; Berg T; Gisslinger B; Kralovics R
Eur J Haematol; 2009 Feb; 82(2):161-3. PubMed ID: 19018861
[No Abstract] [Full Text] [Related]
3. Trisomy 13 in a patient with idiopathic myelofibrosis.
Gozzetti A; Crupi R; Tozzuoli D; Fabbri A; Bocchia M; Lauria F
Cancer Genet Cytogenet; 2005 Jan; 156(2):185. PubMed ID: 15642403
[No Abstract] [Full Text] [Related]
4. Constitutional trisomy 8 mosaicism in primary myelofibrosis: relevance to clinical practice and warning for trisomy 8 studies.
Maserati E; Pressato B; Valli R; Patitucci F; Lo Curto F; Pasquali F; Minelli A; Danesino C; Marchetti M; Barosi G
Cancer Genet Cytogenet; 2007 Nov; 179(1):79-81. PubMed ID: 17981220
[No Abstract] [Full Text] [Related]
5. Skin immunoglobulin deposition following intravenous immunoglobulin therapy in toxic epidermal necrolysis.
Paquet P; Kaveri S; Jacob E; Pirson J; Quatresooz P; Piérard GE
Exp Dermatol; 2006 May; 15(5):381-6. PubMed ID: 16630079
[TBL] [Abstract][Full Text] [Related]
6. Reversal of bone marrow fibrosis in idiopathic myelofibrosis after treatment with alpha-interferon.
Domingues MA; Haepers AT; Massaut IH; Vassallo J; Lorand-Metze I
Haematologica; 1998 Dec; 83(12):1124-5. PubMed ID: 9949632
[TBL] [Abstract][Full Text] [Related]
7. [Myelofibrosis in patients with chronic myeloid leukemia treated with interferon-alpha].
Kumas Sotiris ; Semenova EA; Turkina AG; Zakharova AV; Domracheva EV; Khoroshko ND; Frank GA
Arkh Patol; 2003; 65(4):9-12. PubMed ID: 14518186
[TBL] [Abstract][Full Text] [Related]
8. Partial trisomy 1q in idiopathic myelofibrosis.
Donti E; Tabilio A; Bocchini F; Falzetti F; Martelli MF; Grignani F; Donti GV
Leuk Res; 1990; 14(11-12):1035-40. PubMed ID: 2280601
[TBL] [Abstract][Full Text] [Related]
9. [Transient promyelocytic expansion in primary myelofibrosis].
Ishikawa T; Matsushita A; Nagai K; Shimazaki A; Takahashi T
Rinsho Ketsueki; 1995 Jul; 36(7):700-2. PubMed ID: 7563600
[TBL] [Abstract][Full Text] [Related]
10. Long-term follow-up of a patient with idiopathic myelofibrosis associated with chromosome 11 and 13 abnormalities.
Toubai T; Tanaka J; Higa T; Ota S; Ibata M; Shono Y; Mashiko S; Miura Y; Umehara S; Kahata K; Toyoshima N; Morioka M; Asaka M; Kasai M; Imamura M
Am J Hematol; 2005 Jan; 78(1):67-70. PubMed ID: 15609290
[TBL] [Abstract][Full Text] [Related]
11. Imatinib mesylate in idiopathic and postpolycythemic myelofibrosis.
Hasselbalch HC; Bjerrum OW; Jensen BA; Clausen NT; Hansen PB; Birgens H; Therkildsen MH; Ralfkiaer E
Am J Hematol; 2003 Dec; 74(4):238-42. PubMed ID: 14635203
[TBL] [Abstract][Full Text] [Related]
12. [Osteomyelosclerosis with hepatosplenic myeloid metaplasia associated with trisomy 8].
Dor JF; Givaudan JF; Mattei JF; Mattei MG; Giraud F; Mongin M
Nouv Presse Med; 1977 Oct; 6(33):2997. PubMed ID: 593843
[No Abstract] [Full Text] [Related]
13. A novel cytogenetic abnormality in primary myelofibrosis.
Bae SY; Kim JS; Lee KN; Lee CK; Kim YK; Yoon SY; Lim CS; Cho YJ; Choi CW; Kim WY
Cancer Genet Cytogenet; 2009 Oct; 194(1):65-6. PubMed ID: 19737657
[No Abstract] [Full Text] [Related]
14. Prior poliomyelitis-IVIg treatment reduces proinflammatory cytokine production.
Gonzalez H; Khademi M; Andersson M; Piehl F; Wallström E; Borg K; Olsson T
J Neuroimmunol; 2004 May; 150(1-2):139-44. PubMed ID: 15081258
[TBL] [Abstract][Full Text] [Related]
15. Successful treatment of anemia in idiopathic myelofibrosis with recombinant human erythropoietin.
Hasselbalch HC; Clausen NT; Jensen BA
Am J Hematol; 2002 Jun; 70(2):92-9. PubMed ID: 12111781
[TBL] [Abstract][Full Text] [Related]
16. A novel t(1;2)(p33;q33) in secondary postpolycythemic myelofibrosis.
Panani AD
Cancer Genet Cytogenet; 2009 Dec; 195(2):201-2. PubMed ID: 19963128
[No Abstract] [Full Text] [Related]
17. Subcorneal pustulosis with combined lack of IgG/IgM and monoclonal gammopathy type IgA/Kappa.
Rasch A; Schimmer M; Sander CA
J Dtsch Dermatol Ges; 2009 Aug; 7(8):693-6. PubMed ID: 19243482
[TBL] [Abstract][Full Text] [Related]
18. Interferon Therapy in Myelofibrosis: Systematic Review and Meta-analysis.
Bewersdorf JP; Giri S; Wang R; Podoltsev N; Williams RT; Rampal RK; Tallman MS; Zeidan AM; Stahl M
Clin Lymphoma Myeloma Leuk; 2020 Oct; 20(10):e712-e723. PubMed ID: 32669244
[TBL] [Abstract][Full Text] [Related]
19. Intravenous immunoglobulin in primary and secondary chronic progressive multiple sclerosis: a randomized placebo controlled multicentre study.
Pöhlau D; Przuntek H; Sailer M; Bethke F; Koehler J; König N; Heesen C; Späth P; Andresen I
Mult Scler; 2007 Nov; 13(9):1107-17. PubMed ID: 17623736
[TBL] [Abstract][Full Text] [Related]
20. Myelofibrosis in a child suffering from a hypereosinophilic syndrome with trisomy 8: response to corticotherapy.
Michel G; Thuret I; Capodano AM; Scheiner C; Guitard AM; Mozziconacci MJ; Fossat C; Perrimond H
Med Pediatr Oncol; 1991; 19(1):62-5. PubMed ID: 1990258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
